Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy
Aim: Previous studies demonstrated l-carnitine decreasing doxorubicin-induced cardiotoxicity. Our objectives were to study carnitine levels and cardiac functions in children treated with doxorubicin and the effect of short-term l-carnitine supplements. Materials and Methods: Serial carnitine levels...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2011-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=1;spage=38;epage=42;aulast=Khositseth |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257649862443008 |
|---|---|
| author | Anant Khositseth Suwadee Jirasakpisarn Samart Pakakasama Lulin Choubtuym Duangrurdee Wattanasirichaigoon |
| author_facet | Anant Khositseth Suwadee Jirasakpisarn Samart Pakakasama Lulin Choubtuym Duangrurdee Wattanasirichaigoon |
| author_sort | Anant Khositseth |
| collection | DOAJ |
| description | Aim: Previous studies demonstrated l-carnitine decreasing doxorubicin-induced cardiotoxicity. Our objectives were to study carnitine levels and cardiac functions in children treated with doxorubicin and the effect of short-term l-carnitine supplements. Materials and Methods: Serial carnitine levels and cardiac functions were obtained in children with newly diagnosed solid malignancies before doxorubicin, after cumulative doses of ≥150 mg/m 2 and ≥300 mg/m 2 , respectively. Oral l-carnitine 100 mg/kg/day for 3 days were given to the children treated with doxorubicin at cumulative doses of ≥150 mg/m 2 and ≥300 mg/m 2 . Carnitine levels and cardiac functions were also obtained in those children before and after short-term oral l-carnitine at each cumulative dose of doxorubicin. Results: Five children (3 females), median age of 9.1 years (range 1.5-13 years) with newly diagnosed solid malignancies were enrolled in the study. Free carnitine (FC) tended to decrease while acyl-carnitine (AC) increased making AC/FC ratio increased after cumulative dose of ≥150 and ≥300 mg/m 2 but the statistics was not significant. Left ventricular (LV) systolic function was not significantly changed. Interestingly, LV global function (LV myocardial performance index) was significantly increased after 150 mg/m 2 (median 0.39, 0.27-0.51) and 300 mg/m 2 (median 0.46, 0.27-0.50) when compared to baseline (median 0.28, 0.14-0.48) (P=0.05). Carnitine levels and cardiac functions were not significantly changed after oral l-carnitine supplement at cumulative dose of ≥150 mg/m 2 (n=6) and ≥300 mg/m 2 (n=9). Conclusions: Carnitine levels tended to decrease after doxorubicin treatment. LV global dysfunction was documented early after doxorubicin. However, short-term l-carnitine supplement did not improve cardiac function. |
| format | Article |
| id | doaj-art-482d84042d3140bb8012e6c4aaec0604 |
| institution | OA Journals |
| issn | 0971-5851 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-482d84042d3140bb8012e6c4aaec06042025-08-20T01:56:20ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512011-01-01321384210.4103/0971-5851.81889Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapyAnant KhositsethSuwadee JirasakpisarnSamart PakakasamaLulin ChoubtuymDuangrurdee WattanasirichaigoonAim: Previous studies demonstrated l-carnitine decreasing doxorubicin-induced cardiotoxicity. Our objectives were to study carnitine levels and cardiac functions in children treated with doxorubicin and the effect of short-term l-carnitine supplements. Materials and Methods: Serial carnitine levels and cardiac functions were obtained in children with newly diagnosed solid malignancies before doxorubicin, after cumulative doses of ≥150 mg/m 2 and ≥300 mg/m 2 , respectively. Oral l-carnitine 100 mg/kg/day for 3 days were given to the children treated with doxorubicin at cumulative doses of ≥150 mg/m 2 and ≥300 mg/m 2 . Carnitine levels and cardiac functions were also obtained in those children before and after short-term oral l-carnitine at each cumulative dose of doxorubicin. Results: Five children (3 females), median age of 9.1 years (range 1.5-13 years) with newly diagnosed solid malignancies were enrolled in the study. Free carnitine (FC) tended to decrease while acyl-carnitine (AC) increased making AC/FC ratio increased after cumulative dose of ≥150 and ≥300 mg/m 2 but the statistics was not significant. Left ventricular (LV) systolic function was not significantly changed. Interestingly, LV global function (LV myocardial performance index) was significantly increased after 150 mg/m 2 (median 0.39, 0.27-0.51) and 300 mg/m 2 (median 0.46, 0.27-0.50) when compared to baseline (median 0.28, 0.14-0.48) (P=0.05). Carnitine levels and cardiac functions were not significantly changed after oral l-carnitine supplement at cumulative dose of ≥150 mg/m 2 (n=6) and ≥300 mg/m 2 (n=9). Conclusions: Carnitine levels tended to decrease after doxorubicin treatment. LV global dysfunction was documented early after doxorubicin. However, short-term l-carnitine supplement did not improve cardiac function.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=1;spage=38;epage=42;aulast=KhositsethAnthracyclinecardiac functioncardiac toxicitychildren |
| spellingShingle | Anant Khositseth Suwadee Jirasakpisarn Samart Pakakasama Lulin Choubtuym Duangrurdee Wattanasirichaigoon Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy Indian Journal of Medical and Paediatric Oncology Anthracycline cardiac function cardiac toxicity children |
| title | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| title_full | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| title_fullStr | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| title_full_unstemmed | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| title_short | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| title_sort | carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy |
| topic | Anthracycline cardiac function cardiac toxicity children |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2011;volume=32;issue=1;spage=38;epage=42;aulast=Khositseth |
| work_keys_str_mv | AT anantkhositseth carnitinelevelsandcardiacfunctionsinchildrenwithsolidmalignanciesreceivingdoxorubicintherapy AT suwadeejirasakpisarn carnitinelevelsandcardiacfunctionsinchildrenwithsolidmalignanciesreceivingdoxorubicintherapy AT samartpakakasama carnitinelevelsandcardiacfunctionsinchildrenwithsolidmalignanciesreceivingdoxorubicintherapy AT lulinchoubtuym carnitinelevelsandcardiacfunctionsinchildrenwithsolidmalignanciesreceivingdoxorubicintherapy AT duangrurdeewattanasirichaigoon carnitinelevelsandcardiacfunctionsinchildrenwithsolidmalignanciesreceivingdoxorubicintherapy |